278 filings
Page 5 of 14
8-K
3ky3kv9t
16 Aug 22
BioSig Sees Positive Momentum from Sales Pipeline Growth
9:47am
8-K
sh2g0gldo0y 802e5m
15 Jul 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
t2spf45md211t43
7 Jul 22
BioSig Announces Purchase Agreement with Kansas City Heart Rhythm Institute at Overland Park Regional Medical Center
11:32am
8-K
iou4e3m3 ci
30 Jun 22
BioSig Announces Closing of Public Offering of Common Stock
4:05pm
8-K
kb69in6x9hzw
29 Jun 22
BioSig Announces Proposed Public Offering of Common Stock
9:19am
8-K
4kmmutnjz6wjcyk8t1
17 May 22
Entry into a Material Definitive Agreement
4:57pm
8-K
q1pf5bk2o2w2m jn
11 May 22
BioSig Technologies, Inc. Issues Shareholder Letter with Corporate Update on Recent Achievements
10:31am
8-K
shl 6t3123m
10 May 22
Regulation FD Disclosure
11:51am
8-K
rsdlz3uq6o0n4ly4
2 May 22
Departure of Directors or Certain Officers
4:00pm
8-K
u6goc4
28 Apr 22
Departure of Directors or Certain Officers
11:02am
8-K
q0a5mu5v
29 Mar 22
BioSig Technologies, Inc. Partners with Summit Blue Capital to Provide Equipment Leasing Services
2:25pm
8-K
mcu3 j2zpz
24 Mar 22
Entry into a Material Definitive Agreement
4:54pm
8-K
yy25mb4hosde
22 Mar 22
BioSig Technologies, Inc. Appoints John Sieckhaus as Chief Operating Officer
1:00pm
8-K
sq3ao3h2i958h
26 Jan 22
BioSig Awarded US Patent Claims for its PURE EP™ Noise-Filtering Technology
1:56pm
8-K
t35 de66qi8
21 Dec 21
BioSig Technologies, Inc. Selects Access Strategy Partners to Accelerate Commercial Sales
9:00am
8-K
wx0p6fz4k9f
16 Dec 21
Regulation FD Disclosure
9:16am
8-K
t7i1hnobw0tl0ys
1 Dec 21
BioSig Technologies, Inc. Appoints Gray Fleming as Chief Commercial Officer
9:25am
8-K
m60nyuzwa2g5gq k48hk
16 Nov 21
BioSig Initiates Artificial Intelligence Development Program with Technion – Israel Institute of Technology
3:29pm
8-K
on0bk3
10 Nov 21
BioSig Adds To Its Clinical Footprint In Texas
9:20am
8-K
4z15pym
8 Nov 21
Regulation FD Disclosure
11:31am